Blue Owl Capital related stories
All articles and analysis
Side Letter: Dyal's debt play, ADIA on data, Partners Group growthDyal has another way of accessing GP economics for its investors and we have the details. Here’s today's brief, for our valued subscribers only.
Dyal eyes more than $8bn for latest PE fund and ponders 2020 returnThe fund initially targeted as much as $6bn and was due to close on more than $7bn in the first quarter of this year.
Investors you need to meet: Stephen MoseleyThe head of alternative investments at the $64bn Alaska Permanent Fund Corporation has an eye for new strategies and emerging managers.
GP stakes: Who's on the shopping list?PAI Partners, Affinity Equity Partners and Coller Capital are among the most suitable candidates for a GP stake investment, according to a report.
Side Letter: GP interests, HarbourVest secondaries, VC starter kitSteve Mnuchin’s chief of staff joins Blackstone, Dover Street's fund terms revealed. Here’s today's brief, for our valued subscribers only.
Side Letter: Riverside's reins, a slice of Oak for AlpInvest, secret impactWhen it comes to sovereigns investing in tech, the Singaporeans have led the way; others have followed. Here’s today's brief, for our valued subscribers only.
High asset prices threaten GP fee revenues – reportCompressed exit multiples could have a material impact on performance fee income, according to tech platform Cobalt.
GP interests: Niche work if you can get itFunds that buy stakes in private equity firms are hot property; but growth in that segment is naturally constrained.
Dyal to close Fund IV on more than $7bn in Q1 – exclusiveDyal was initially targeting $6bn but is likely to raise significantly more after completing six deals from Fund IV in 2018, PEI understands.
AlpInvest shelves fund of firms fundraising – exclusiveThe firm has decided not to continue capital raising for its fund focused on acquiring stakes in private equity GPs, PEI has learned.